These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6099710)

  • 1. Disparate response of encephalomyocarditis virus and MM virus to interferon in JLS-V9R cells.
    Czarniecki CW; Allen PT
    Antiviral Res; 1984 Dec; 4(6):351-5. PubMed ID: 6099710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.
    Allen PT; Schellekens H; Van Griensven LJ; Billiau A
    J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential antiviral effects of interferon in three murine cell lines.
    Sen GC; Herz RE
    J Virol; 1983 Mar; 45(3):1017-27. PubMed ID: 6187940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of human leukocyte and immune interferons on the reproduction and cytopathogenic effect of the encephalomyocarditis virus in mice].
    Mentkevich LM; Zhdanova LV; Meshkova EN
    Vopr Virusol; 1984; 29(5):582-5. PubMed ID: 6097046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin potentiates TNF-induced antiviral activity.
    Ohnishi E; Bannai H
    Antiviral Res; 1993 Dec; 22(4):327-31. PubMed ID: 8279819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.
    Kawamoto S; Oritani K; Asada H; Takahashi I; Ishikawa J; Yoshida H; Yamada M; Ishida N; Ujiie H; Masaie H; Tomiyama Y; Matsuzawa Y
    J Virol; 2003 Sep; 77(17):9622-31. PubMed ID: 12915574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Properties of human alpha-interferon F and hybrid interferon F/D obtained from recombinant bacteria compared to the properties of an interferon preparation from human leukocytes].
    Ovchinnikov IuA; Sverdlov ED; Tsarev SA; Monastyrskaia GS; Khodkova EM
    Dokl Akad Nauk SSSR; 1983; 268(4):996-1000. PubMed ID: 6187523
    [No Abstract]   [Full Text] [Related]  

  • 8. Human interferon-alpha-and-gamma-mediated inhibition of retrovirus production in the absence of an inhibitory effect on vesicular stomatitis virus and encephalomyocarditis virus replication in RD-114 cells.
    Herz RE; Rubin BY; Sen GC
    Virology; 1983 Feb; 125(1):246-50. PubMed ID: 6299008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses.
    Leavitt R; Schlesinger S; Kornfeld S
    J Virol; 1977 Jan; 21(1):375-85. PubMed ID: 189071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain.
    Carter CC; Gorbacheva VY; Vestal DJ
    Arch Virol; 2005 Jun; 150(6):1213-20. PubMed ID: 15717119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.
    Ahmed CM; Burkhart MA; Subramaniam PS; Mujtaba MG; Johnson HM
    J Virol; 2005 May; 79(9):5632-9. PubMed ID: 15827178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids.
    Sen GC; Herz R; Davatelis V; Pestka S
    J Virol; 1984 May; 50(2):445-50. PubMed ID: 6200607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on interferon-sensitive cells derived from the interferon-resistant NIH 3T3 clone 1 line.
    Mittnacht S; Jacobsen H
    Prog Clin Biol Res; 1985; 202():237-45. PubMed ID: 2421304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-produced viral inhibitor: possible mechanism of action and chemical composition.
    Hughes TK; Blalock JE; McKerlie ML; Baron S
    Infect Immun; 1981 May; 32(2):454-7. PubMed ID: 6265357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of human lymphoblastoid interferon on HeLa cells infected with RNA-containing animal viruses.
    Muñoz A; Carrasco L
    J Gen Virol; 1984 Feb; 65 ( Pt 2)():377-90. PubMed ID: 6319580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta inhibits the antiviral action of interferons in human embryonic fibroblasts.
    Zielińska-Jenczylik J; Inglot AD; Inglot O; Popik W
    J Interferon Res; 1991 Apr; 11(2):87-9. PubMed ID: 1714487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of human recombinant and lymphoblastoid interferons in human and heterologous cell lines.
    Overall JC; Yeh TJ; Kern ER
    J Interferon Res; 1984; 4(4):529-33. PubMed ID: 6094683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin and aspirin do not inhibit the antiviral or anti-proliferative actions of interferon.
    Tovey MG; Gresser I; Rochette-Egly C; Begon-Lours-Guymarho J; Bandu MT; Maury C
    J Gen Virol; 1982 Dec; 63(2):505-8. PubMed ID: 6185629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon aerosol suppression of vesicular stomatitis virus replication in the lungs of infected mice.
    Wyde PR; Wilson SZ; Sun CS; Knight V
    Antimicrob Agents Chemother; 1984 Oct; 26(4):450-4. PubMed ID: 6097164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of bovine interferons on primate cells.
    Tovey MG; Bandu MT; Begon-Lours J; Brouty-Boyé D; Gresser I
    J Gen Virol; 1977 Aug; 36(2):341-4. PubMed ID: 197203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.